• Contact
  • EPAD Academy
  • EPAD LCS Research Access
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
      • Project Deliverables
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • For Research Participants
    • Why Participate in EPAD?
      • EPAD & Dementia Research
      • Our Progress
    • Participation in EPAD Trials
    • EPAD Cohort Study
      • Trial Locations
      • EPAD Study Visits
    • EPAD Stories
    • Participation FAQs
  • For Intervention Owners
    • The EPAD Platform
      • Terms of Reference
    • EPAD Benefits
    • Clinical Candidate Selection
      • EPAD Application Process
    • EPAD FAQs
    • Research Resources
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Events
Menu back  

WP1 Deliverable 1.6- Interim report on evaluation of biomarker and clinical assessments and outcomes from existing and acquired data

Download

- Stars (0)

293 Downloads

Owner: EPAD Administrator

Version: 1.0

Last Updated: 30-01-2019

DescriptionPreviewVersions
115736_EPAD_D1.6_Interim report on evaluation of biomarker and clinical assessments and outcomes from existing and acquired data_Final.pdf
Share this post
FacebookTwitterLinkedInGoogle+
Latest News
  • Spotlight on Fundació ACE
    2019-11-29
  • EPAD baseline data V500.0 published in the Journal of Prevention of Alzheimer’s disease
    2019-11-27
  • The European Prevention of Alzheimer’s Dementia releases its first wave of data
    2019-11-18
  • Interview with Laura Carrera Carballés
    2019-11-04
  • Interview with Ross Dunne
    2019-10-30
Subscribe to our Newsletter

View the EPAD Brochure
thumbnail of EPAD brochure
Speak to the EPAD team
thumbnail of speech bubbles
Twitter
Twitter
EPAD
EPAD
@IMI_EPAD

.@IMI_EPAD research participants are enthusiastic about the move to make their data available to researchers. "Research participants love and expect it - they want as much knowledge to be gained as possible from their contribution" said @craig_ritchie68 imi.europa.eu/news-events/ne… twitter.com/IMI_JU/status/…

reply retweet favorite
3:08 pm · 2019-12-12
Twitter
EPAD
EPAD
@IMI_EPAD

Baseline data from the first 500 research participants (V500.0) for the @IMI_EPAD Longitudinal Cohort Study are available. #datasharing #milestone #openscience More information on data availability here: bit.ly/EPAD_v500_0 pic.twitter.com/jZNmSwVj5R

reply retweet favorite
7:57 am · 2019-12-04
Twitter
EPAD
EPAD
@IMI_EPAD

“@IMI_EPAD is an innovative and highly ambitious project because it is based on the belief that we’ll get to preventively treat #Alzheimer's disease. This message aims to change the concept of prediction or #prevention to the concept of healing.”, said @MerceBoadaR @FundacioACE twitter.com/IMI_EPAD/statu…

reply retweet favorite
7:37 am · 2019-12-03
Twitter
EPAD
EPAD
@IMI_EPAD

Pleased to announce that Sheffield (UK) has recruited its first research participants in the @IMI_EPAD Longitudinal Cohort Study! EPAD has now 28 sites enrolling. Congratulations and well done to all involved! @IMI_JU @EFPIA @EU_H2020 pic.twitter.com/yBDQF9FU6S

reply retweet favorite
10:19 am · 2019-12-02
Twitter
EPAD
EPAD
@IMI_EPAD

We would love to catch up at #CTAD19 next week. Our #epadista Isabelle Carrie will be presenting an @IMI_EPAD poster. Come and visit us at Poster #5 twitter.com/IMI_EPAD/statu…

reply retweet favorite
2:10 pm · 2019-11-29
Copyright © 2015-19 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Necessary Always Enabled